SZT2 p.Ala1326Val
c.3977C>T · rs747241860 · VCV433088
Computational evidence
| Protein change | ||
| AlphaMissense | 0.6368 | likely pathogenic |
|---|---|---|
| REVEL | 0.647 | pathogenic-leaning |
| ⇒ AlphaMissense and REVEL both call this damaging. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · C>A here scores Δ0.59 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 7.6 | GERP 1.7, phastCons 1 |
| Regional constraint | o/e 0.92 | unconstrained · MANE · 15 kb · p 0.00032 · regional, not allelic |
| Overall | ||
| CADD | 28.4 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 0.00937% | 10,672 |
| Remaining individualsnot grpmax-eligible | 0.0048% | 20,829 |
| European (non-Finnish)grpmax | 0.00381% | 26,223 |
| East Asian | 0.00223% | 44,892 |
| South Asian | 0.0011% | 91,090 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- SZT2
- Protein
- p.Ala1326Val
- Coding
- c.3977C>T
- MANE Select
- NM_001365999
- dbSNP
- rs747241860
- Type
- single nucleotide variant
- Location
- chr1:43428297 (GRCh38)
- Gene constraint
- LOEUF 0.582 · pLI <0.01 (gnomAD)
- Residue 1326
- a UniProt-annotated variant site (in dee18)
Disease context
self-limited epilepsy with centrotemporal spikes — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Self-limited epilepsy with centrotemporal spikes (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Childhood
Similar variants
- SZT2 p.Ala1326= Likely benign ★★ same residue
- SZT2 p.Ala1326Thr Uncertain significance ★ same residue
- SZT2 p.Ala938Thr Uncertain significance ★★ ⚠ same condition
- SZT2 p.Arg1379Trp Uncertain significance ★★ ⚠ same condition
- SZT2 p.Arg1722His Uncertain significance ★★ ⚠ same condition
- SZT2 p.Arg1839Cys Uncertain significance ★★ ⚠ same condition
- SZT2 p.Met2629Ile Uncertain significance ★★ ⚠ same condition
- SZT2 p.Thr2980Ile Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/szt2-p-ala1326val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown